Articles Tagged With: treatment
-
New Data on Opioid Prescribing Guidelines and ED Practice
Opioid prescribing guidelines were linked to small changes in morphine equivalent units ordered in the ED, according to the authors of a study.
-
Legal Standard of Care Is Evolving for ED Patients with Opioid Use Disorder
An ED visit from someone with opioid use disorder is an opportunity to put that person in treatment. People do not present to the ED when things are going well; they present at times of crisis. Sometimes, in that crisis, there is a wakeup. If the system offers some approaches and a treatment pathway, then everybody benefits.
-
Efficacy and Safety of Cannabidiol in Treatment of Focal Seizures Associated with Tuberous Sclerosis Complex
Cannabidiol used as an add-on therapy for intractable focal seizures in patients with tuberous sclerosis complex was efficacious. Cannabidiol also had an acceptable adverse event profile, but frequently induced transient elevation of liver enzymes.
-
Long-Term Treatment of Hereditary Amyloid Neuropathy with Patisiran
Hereditary transthyretin-mediated amyloidosis with polyneuropathy is effectively treated by patisiran, a lipid nanoparticle ribonucleic acid interference that binds to transthyretin (TTR) messenger RNA and inhibits TTR production in the liver, resulting in reduction of the serum TTR concentration. Treatment effect has been sustained during a five-year open-label extension study.
-
Oral Moxifloxacin vs. Intravenous Ertapenem Followed by Oral Levofloxacin and Metronidazole for Acute Appendicitis
A randomized controlled clinical trial found that a seven-day course of oral moxifloxacin was not noninferior to two days of intravenous ertapenem followed by five days of levofloxacin and metronidazole in adults with uncomplicated acute appendicitis.
-
Elderly Patients with Esophageal Cancers Might Tolerate Multimodal Therapy Well
Some clinicians shy away from complete therapy courses for these patients over concerns about frailty, quality of life.
-
Streamlined Lyme Disease Guidelines for Frontline Providers
With the peak period for Lyme disease approaching, new guidelines help clinicians understand when to consider the ailment in patients who present to the ED, how to properly diagnosis a case, and how to treat.
-
Prednisone vs. Placebo in Short-Term Prevention of Episodic Cluster Headaches
Prednisone, given at 100 mg for five days and then tapering by 20 mg every three days, is a safe and effective short-term prevention for episodic cluster headaches while waiting for longer-acting preventive agents to be initiated.
-
Cognitive Benefit of Rivastigmine in Parkinson’s Disease Dementia with Orthostatic Hypotension
Individuals with Parkinson’s disease dementia and orthostatic hypotension (OH) have more robust cognitive improvement from rivastigmine compared to those without OH. This greater response possibly is mediated by the anti-OH effect of rivastigmine.
-
Focused Ultrasound in Parkinson’s Disease: Going Beyond Tremor
In this randomized controlled trial, patients with asymmetric Parkinson’s disease were assigned to noninvasive, focused ultrasound-mediated subthalamotomy or sham procedure. The authors reported improved motor function in the focused ultrasound group, with adverse events including weakness, dyskinesia, and gait disturbances.